ABCL Free Cash Flow
Operating cash flow less capital expenditures — the cash a business keeps after funding itself.
Free Cash Flow
Latest: $24M (2026Q2)
| Period | Value |
|---|---|
| 2023Q1 | -$59M |
| 2023Q2 | -$7M |
| 2023Q3 | -$20M |
| 2023Q4 | -$34M |
| 2024Q1 | -$66M |
| 2024Q2 | -$50M |
| 2024Q3 | -$47M |
| 2024Q4 | -$24M |
| 2025Q1 | -$22M |
| 2025Q2 | -$46M |
| 2025Q3 | -$62M |
| 2025Q4 | -$45M |
| 2026Q1 | -$37M |
| 2026Q2 | $24M |
Other Indicators
Other ABCL Charts
More quarter-by-quarter fundamentals for AbCellera Biologics Inc.
1 / 6
Revenue
EPS
FCF Margin
Cumulative FCF
Shares Outstanding
Total Assets
Healthcare Comparison
1 / 3
Free Cash Flow
Free Cash Flow
Free Cash Flow
Latest Free Cash Flow: $24M (2026Q2).
Across the 14 quarters from 2023Q1 to 2026Q2, Free Cash Flow ranged from -$66M in 2024Q1 to $24M in 2026Q2.